Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.

The apolipoprotein E (APOE) gene has been consistently shown to be a major genetic risk factor; however, all cases of Alzheimer's disease (AD) cannot be attributed to the epsilon4 variant of APOE, because about half of AD patients have the APOE-epsilon3*3 genotype. To identify an additional genetic risk factor(s), we performed large-scale single nucleotide polymorphism (SNP)-based association analysis of 1526 late-onset AD patients and 1666 control subjects in a Japanese population. We prepared two independent sets consisting of exploratory and validation samples, respectively, with only the APOE-epsilon3*3 genotype, and first carried out genotyping for the exploratory set with 1206 SNPs in the region between 60 and 107 Mb on chromosome 10q that is implicated by linkage studies as containing an AD susceptibility locus. Thirty-five SNPs that showed significant values (P<0.01) were followed-up to detect any association with the validation samples. Finally, six SNPs exhibited replicated significant associations (P=0.000035-0.00048) on meta-analysis of both sets. These SNPs were clustered in a locus spanning 220 kb at genomic position 101 Mb, and three of the six SNPs were located in the dynamin-binding protein (DNMBP) gene. Quantitative real-time RT-PCR analysis demonstrated that neuropathologically confirmed AD brains exhibit a significant reduction of DNMBP mRNA compared with age-matched ones (P<0.0169). Thus, we confirmed the association of DNMBP with AD individuals with the APOE-epsilon3*3 genotype or lacking the epsilon4 allele, and DNMBP may be one of the susceptibility genes for AD.

[1]  N. Risch Linkage strategies for genetically complex traits. I. Multilocus models. , 1990, American journal of human genetics.

[2]  Adriana B Ferreira,et al.  Beta-amyloid-induced dynamin 1 depletion in hippocampal neurons. A potential mechanism for early cognitive decline in Alzheimer disease. , 2005, The Journal of biological chemistry.

[3]  Eden R Martin,et al.  Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. , 2003, Human molecular genetics.

[4]  J. She,et al.  Molecular Cloning and Characterization of a Novel Mammalian Endo-apyrase (LALP1)* , 2001, The Journal of Biological Chemistry.

[5]  S. Younkin,et al.  Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. , 2003, Human molecular genetics.

[6]  N. Risch Linkage strategies for genetically complex traits. II. The power of affected relative pairs. , 1990, American journal of human genetics.

[7]  K. Takata,et al.  Possible involvement of Wiskott–Aldrich syndrome protein family in aberrant neuronal sprouting in Alzheimer's disease , 2003, Neuroscience Letters.

[8]  A D Roses,et al.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Owen,et al.  Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. De Camilli,et al.  The stimulatory action of amphiphysin on dynamin function is dependent on lipid bilayer curvature , 2004, The EMBO journal.

[11]  Margaret A. Pericak-Vance,et al.  Genetic Analysis of Complex Disease , 2006 .

[12]  M. Owen,et al.  A full genome scan for late onset Alzheimer's disease , 1999 .

[13]  R. Nitsch,et al.  Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2 , 2003, Neurogenetics.

[14]  M. Picciotto,et al.  Decreased Synaptic Vesicle Recycling Efficiency and Cognitive Deficits in Amphiphysin 1 Knockout Mice , 2002, Neuron.

[15]  Taylor J. Maxwell,et al.  A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. , 2006, American journal of human genetics.

[16]  L. Feuk,et al.  Sequence variants of IDE are associated with the extent of β-amyloid deposition in the Alzheimer's disease brain , 2005, Neurobiology of Aging.

[17]  Adriana B Ferreira,et al.  β-Amyloid-induced Dynamin 1 Depletion in Hippocampal Neurons , 2005, Journal of Biological Chemistry.

[18]  E M Wijsman,et al.  The number of trait loci in late-onset Alzheimer disease. , 2000, American journal of human genetics.

[19]  P. Coleman,et al.  Defects in expression of genes related to synaptic vesicle traffickingin frontal cortex of Alzheimer’s disease , 2003, Neurobiology of Disease.

[20]  M G McInnis,et al.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.

[21]  R. Petersen,et al.  Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Aβ42 levels and risk for Alzheimer disease , 2004, Human mutation.

[22]  M. Owen,et al.  Variation in the urokinase‐plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[23]  Rajesh Pahwa,et al.  Age at onset in two common neurodegenerative diseases is genetically controlled. , 2002, American journal of human genetics.

[24]  Mitsutoshi Yamamoto,et al.  No association between the insulin degrading enzyme gene and Alzheimer's disease in a Japanese population , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[25]  M. Owen,et al.  Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease , 2001, Human Genetics.

[26]  D. Selkoe Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[27]  Yusuke Nakamura,et al.  Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro , 2004, Nature.

[28]  H. Elsässer,et al.  A human intracellular apyrase-like protein, LALP70, localizes to lysosomal/autophagic vacuoles. , 1999, Journal of cell science.

[29]  R. Kaji,et al.  Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer’s disease , 2004, Neuroscience Letters.

[30]  J. Hinshaw Dynamin and Its Role in Membrane Fission , 2022 .

[31]  M. Owen,et al.  Full genome screen for Alzheimer disease: stage II analysis. , 2002, American journal of medical genetics.

[32]  M. Owen,et al.  Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease. , 2004, Neuromolecular medicine.

[33]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[34]  Yoshimi Takai,et al.  Induction of filopodium formation by a WASP-related actin-depolymerizing protein N-WASP , 1998, Nature.

[35]  M. Owen,et al.  Susceptibility locus for Alzheimer's disease on chromosome 10. , 2000, Science.

[36]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Sever,et al.  Dynamin and endocytosis. , 2002, Current opinion in cell biology.

[38]  J L Haines,et al.  Genetic Analysis of Complex Diseases , 1997, Science.

[39]  J. Blangero,et al.  Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. , 2000, Science.

[40]  L. Feuk,et al.  Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. , 2005, Human molecular genetics.

[41]  D. Keppler,et al.  Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2). , 2002, European journal of biochemistry.

[42]  M. Albert,et al.  Results of a high-resolution genome screen of 437 Alzheimer's disease families. , 2003, Human molecular genetics.

[43]  A. Hofman,et al.  Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. , 1998, Archives of neurology.

[44]  P. De Camilli,et al.  Tuba, a Novel Protein Containing Bin/Amphiphysin/Rvs and Dbl Homology Domains, Links Dynamin to Regulation of the Actin Cytoskeleton* , 2003, Journal of Biological Chemistry.

[45]  F. Jessen,et al.  Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke , 2004, Neurology.